⌕
Johnson & Johnson · JNJ · NYSE
Tenet 48 · Mixed
Compare
$282.55−1.12%At closeTenet 48 · Mixed
$282.55−3.20 (−1.12%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD
$282.70+0.15 (+0.05%)
After hours: Nov 16, 2026, 6:02 PM ET

Johnson & Johnson (JNJ) Stock

Johnson & Johnson (JNJ) closed at $282.55 on Nov 16, 2026; its Tenet Score is 48 of 100 against 313 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

Key stats

Previous close
$282.55
Nov 16, 2026
Market cap
$687.9B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
43.5×
price ÷ earnings
Dividend yield
1.85%
past year's regular dividends ÷ price
52-week range
193.45 – 288.11
low → high · as of close, Nov 13, 2026
Tenet Score
48/100
Mixed · 313 Healthcare peers

Industry: Drugs

Johnson & Johnson scores 48/100. Mixed. Value is the soft spot, trading at 43× earnings versus 313 Healthcare peers.

Tenet Score · vs sector

n=313
48/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
34
Quality
65
Health
39
Growth
54

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueDQualityCHealthDGrowthCMomentumB
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
8.4×
price to book value
P/S
6.9×
price to fiscal 2025 sales
ROE
20%
return on equity
Operating margin
26.8%
fiscal 2025, before interest and tax
Net margin
16.2%
of revenue kept
Current ratio
1.02
current assets to liabilities
Net debt / EBITDA
0.8×
leverage, net of cash
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.

The whole report, at a glance · every card is a live peek, click any to open the section

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brand…

Composite computed Nov 13, 2026 · peer basis: Healthcare (n=313) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 514 US ETFs · top wrappers by weightSee all ETFs holding JNJ →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

CompanyTenet ScoreMarket cap
Lilly(Eli) & CoLLY49$1.29T
Abbvie IncABBV42$521.5B
Merck & Co IncMRK41$364.3B
Novartis AGNVS56$306.3B
AMGEN Inc.AMGN47$251.9B
Gilead Sciences, Inc.GILD37$208.5B
Novo NordiskNVO63$185.9B
Pfizer Inc.PFE50$164.7B
Vertex Pharmaceuticals, Inc.VRTX55$136.6B
Bristol-Myers Squibb Co.BMY51$129.7B

Compare Johnson & Johnson with

What sector and industry is Johnson & Johnson in?

Johnson & Johnson is in the Healthcare sector and the Drugs industry.

What is Johnson & Johnson's Tenet Score?

Johnson & Johnson's Tenet Score is 48 out of 100, ranked against 313 Healthcare peers as of Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.